洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

首页 临床进展 Single shot versus continuous saphenous nerve block for postoperative pain management after total knee replacement: a randomised, double-blind trial

【ChiCTR-IIR-17011735】Single shot versus continuous saphenous nerve block for postoperative pain management after total knee replacement: a randomised, double-blind trial

查看原文
立即下载
基本信息
登记号

ChiCTR-IIR-17011735

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2017-06-22

临床申请受理号

/

靶点

/

适应症

Primary osteoarthritis of knee undergoing total knee replacement

试验通俗题目

Single shot versus continuous saphenous nerve block for postoperative pain management after total knee replacement: a randomised, double-blind trial

试验专业题目

Single shot versus continuous saphenous nerve block for postoperative pain management after total knee replacement: a randomised, double-blind trial

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

852

联系人通讯地址
请登录查看
临床试验信息
试验目的

To investigate and compare the effect of single shot versus continuous saphenous nerve blockade on pain control in the early postoperative period for patients undergoing unilateral primary total knee replacement.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

Ⅳ期

随机化

Randomization will be performed by computer program and the results will be sealed in concealed envelops.

盲法

/

试验项目经费来源

Departmental funding

试验范围

/

目标入组人数

30

实际入组人数

/

第一例入组时间

2017-10-01

试验终止时间

2018-06-30

是否属于一致性

/

入选标准

1. Primary, unilateral total knee replacement under central neuroaxial block; 2. Aged 18 to 80 years; 3. American Society of Anesthesiologists (ASA) physical status I – III.；

排除标准

1. Patients with secondary osteoarthritis of the knee; 2. Patients undergoing operation under general anaesthesia; 3. Pregnancy; 4. Body weight < 45 kg or body mass index > 40 kg/m2; 5. Allergy to opioid or local anaesthetics; 6. Patients with contraindications to COX-2 inhibitors use; 7. Chronic opioid use (> 1 month of 60mg morphine oral equivalents daily); 8. Subject refusal.；

研究者信息
研究负责人姓名
请登录查看
试验机构

Department of Anaesthesia and Intensive Care, Pok Oi Hospital

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

852

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

Department of Anaesthesia and Intensive Care, Pok Oi Hospital的其他临床试验

更多

Department of Anaesthesia and Intensive Care, Pok Oi Hospital的其他临床试验

更多

最新临床资讯

更多
摩熵医药企业版
50亿+条医药数据随时查
7天免费试用
体验产品